4-(5-氯-2-硝基苯基)-吗啉 | 65976-63-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 中文名称: 4-(5-氯-2-硝基苯基)-吗啉
• 英文名称: 4-(5-chloro-2-nitrophenyl)morpholine
• CAS: 65976-63-8
• 化学式: C₁₀H₁₁ClN₂O₃
• mdl: MFCD00448347
• 分子量: 242.662
• InChiKey: BDBMOQCOLZWAIO-UHFFFAOYSA-N

物化性质

• 熔点：
  71-73°
• 溶解度：
  >36.4 [ug/mL]

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  58.3
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2934999090

反应信息

• 作为反应物：
  描述：

  4-(5-氯-2-硝基苯基)-吗啉 在 吡啶 、 potassium phosphate 、 palladium diacetate 、 铁粉 、 氯化铵 、 4,5-双二苯基膦-9,9-二甲基氧杂蒽 作用下， 以 乙醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 48.0h， 生成 N-(4-(dimethylphosphoryl)-2-morpholinophenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
  参考文献：
  名称：

  [EN] PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS
  [FR] DÉRIVÉS PYRAZOLO [1,5 A]PYRIMIDINE EN TANT QUE MODULATEURS D'IRAK 4

  摘要：

  公开号：

  WO2017108723A3
• 作为产物：
  描述：

  吗啉 、 2,4-二氯硝基苯 生成 4-(5-氯-2-硝基苯基)-吗啉
  参考文献：
  名称：

  Discovery of novel FMS kinase inhibitors as anti-inflammatory agents

  摘要：

  The optimization of the arylamide lead 2 resulted in identification of a highly potent series of 2,4-disubstituted arylamides. Compound 8 (FMS kinase IC50 = 0.0008 mu M) served as a proof-of-concept candidate in a collagen-induced model of arthritis in mice. (c) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.01.059

文献信息

• Materials and methods to potentiate cancer treatment
  申请人：——

  公开号：US20020165218A1

  公开（公告）日：2002-11-07

  Compounds that inhibit DNA-dependent protein kinase, compositions comprising the compounds, methods to inhibit the DNA-PK biological activity, methods to sensitize cells the agents that cause DNA lesions, and methods to potentiate cancer treatment are disclosed.

  抑制DNA依赖性蛋白激酶的化合物，包含这些化合物的组合物，抑制DNA-PK生物活性的方法，使细胞对引起DNA损伤的药物敏感的方法，以及增强癌症治疗的方法被披露。
• Aromatic Nucleophilic Substitution of Halobenzenes with Amines under High Pressure
  作者：Toshikazu Ibata、Yasushi Isogami、Jiro Toyoda

  DOI：10.1246/bcsj.64.42

  日期：1991.1

  The nucleophilic substitution reactions of aromatic halides having electron-attracting groups on ortho or para position with various primary and secondary amines were accelerated by high pressure to give the corresponding N-substituted anilines in high yields. The bulkiness of amines affects its reactivity to lower the yields of the products. Although the secondary amines are usually less reactive

  在邻位或对位具有吸电子基团的芳族卤化物与各种伯胺和仲胺的亲核取代反应通过高压加速，以高产率得到相应的N-取代苯胺。胺的体积大会影响其反应性，从而降低产品的产率。尽管仲胺的反应性通常低于伯胺，但发现环状仲胺如吗啉、哌啶和吡咯烷的反应性非常高。与无环叔胺的低反应性相比，1,4-二氮杂双环 [2.2.2] 辛烷和奎宁环以高产率得到 N-季铵卤化物。二氯-和三氯-硝基苯也与二乙胺、吡咯烷和吗啉反应生成单-、二-、
• Specific features of nucleophilic substitution in 1-chloro-3,4-dinitrobenzene
  作者：N. V. Zotova、P. M. Kushakova、V. A. Kuznetsov、A. A. Rodin、A. V. Garabadzhiu

  DOI：10.1007/s11178-005-0043-z

  日期：2004.10

  Effects of the solvent, temperature, and nucleophile nature on the selectivity of nucleophilic substitution in 1-chloro-3,4-dinitrobenzene were studied, and optimal conditions were found for the synthesis and isolation of particular products.

  研究了溶剂、温度和亲核物性质对 1-氯-3,4-二硝基苯亲核取代选择性的影响，并找到了合成和分离特定产物的最佳条件。
• Regular Trends in Nucleophilic Substitutions in 2-Alkylamino-4-chloronitrobenzenes
  作者：N. V. Zotova、P. M. Kushakova、V. A. Kuznetsov、A. A. Rodin、A. V. Garabadzhiu

  DOI：10.1007/s11178-005-0146-6

  日期：2005.2

  The effect of substituents in position 2 on the reactivity of 2-alkylamino-4-chloronitrobenzenes in nucleophilic substitution by N-nucleophiles of various character was studied.

  研究了位置 2 上的取代基对 2-烷基氨基-4-氯硝基苯在不同性质的 N-亲核物亲核取代中的反应性的影响。
• Inhibitors of c-fms kinase
  申请人：Illig R. Carl

  公开号：US20060100201A1

  公开（公告）日：2006-05-11

  The invention relates to compounds of Formula I: wherein A, X, R 2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, colon cancer, stomach cancer, hairy cell leukemia and non-small lung carcinoma; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including arthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.

  本发明涉及公式I的化合物：其中A、X、R2和W在说明书中设置，以及其溶剂化物、水合物、互变异构体和药学上可接受的盐，它们抑制蛋白酪氨酸激酶，特别是c-fms激酶。本发明还提供了利用公式I的化合物治疗自身免疫性疾病和具有炎症成分的疾病；治疗卵巢癌、子宫癌、乳腺癌、结肠癌、胃癌、毛细胞白血病和非小细胞肺癌的转移；以及治疗疼痛，包括肿瘤转移或骨关节炎引起的骨骼疼痛，或内脏、炎症和神经性疼痛；以及骨质疏松症、Paget病和其他骨吸收介导的疾病，包括关节炎、假体失效、骨溶性肉瘤、骨髓瘤和肿瘤转移至骨骼。